Eris Lifesciences

BSE: 540596 | NSE: ERIS
Eris Lifesciences (CIN: L24232GJ2007PLC049867) operates in the Pharmaceuticals industry and has been listed in the stock market since 29th Jun 2017. It currents trades on NSE with symbol ERIS and on BSE with scrip code 540596.
The registered office of the company is 8th floor, Commerce House IV, Beside Shall Petrol Pump, 100 Feet Road, Prahladnagar,Ahmedabad,Gujarat,380015.

The management team of Eris Lifesciences is led by Mr. Amit Indubhushan Bakshi who is the Executive Director-Chairperson related to Promoter-MD. Other members of the management team consist of Mr. Inderjeet Singh Negi (Designation:Executive Director), Sachin Shah (Designation:Chief Financial Officer), Mrs. Vijaya Sampath (Designation:Non-Executive - Independent Director), Mr. Kirit Nanubhai Shelat (Designation:Non-Executive - Independent Director), Mr. Prashant Gupta (Designation:Non-Executive - Independent Director), Mr. Kaushal Kamlesh Shah (Designation:Director), Milind Talegaonkar (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Eris Lifesciences is as below -

BSE 541.95 11.95 (2.25%)

BSE

541.95 11.95 (2.25%)
Volume: 10,834.00
M. Cap: 7,360.00
P/E: 24.83
Prev. Close: 531.35
Day
52 Wk
Symbol is not Traded Today for NSE

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 7,54,31,423 55.55
Foreign Institutions 1,37,20,924 10.11
NBFC and Mutual Funds 1,44,71,079 10.66
Others 5,10,478 0.38
General Public 3,07,30,567 22.63
Financial Institutions 9,16,182 0.67
Total 13,57,80,653 100

Financial Data

Consolidated
Figures in crore 2020 2019 2018
Net Sales 1,074.06 982.16 855.60
Operating Profit 383.92 376.77 348.52
Other Income 15.40 31.69 26.41
Interest 2.30 23.06 10.65
Depreciation 50.26 36.35 25.64
Profit Before Tax 331.36 317.36 312.23
Tax 34.85 26.21 17.25
Profit After Tax 296.51 291.15 294.98
Share Capital 13.58 13.75 13.75
Reserves 1,282.76 1,136.77 847.56
Net Worth 1,296.34 1,150.52 861.31
Loans 0.00 176.42 376.80
Gross Block 983.89 838.26 819.52
Investments 77.99 355.85 365.37
Cash 67.33 7.51 10.64
Debtors 156.88 83.98 66.64
Net Working Capital 360.44 230.54 130.39
Operating Profit Margin (%) 35.74 38.36 40.73
Net Profit Margin (%) 27.61 29.64 34.48
Earning Per Share (Rs) 21.84 21.15 21.39
Dividend (%) 287.00 0.00 0.00
Dividend Payout 38.97 0.00 0.00
Standalone
Figures in crore 2020 2019 2018
Net Sales 1,020.23 896.54 760.60
Operating Profit 370.44 366.27 344.16
Other Income 14.73 32.50 28.22
Interest 1.97 22.90 10.48
Depreciation 44.88 31.59 21.79
Profit Before Tax 323.59 311.78 311.89
Tax 32.32 26.40 18.23
Profit After Tax 291.27 285.38 293.66
Share Capital 13.58 13.75 13.75
Reserves 1,286.12 1,142.26 854.43
Net Worth 1,299.70 1,156.01 868.18
Loans 33.99 199.65 393.98
Gross Block 695.65 551.81 532.93
Investments 320.30 580.47 545.60
Cash 64.95 6.47 8.81
Debtors 140.82 75.90 60.50
Net Working Capital 408.37 288.59 226.81
Operating Profit Margin (%) 36.31 40.85 45.25
Net Profit Margin (%) 28.55 31.83 38.61
Earning Per Share (Rs) 21.45 20.75 21.36
Dividend (%) 287.00 0.00 0.00
Dividend Payout 38.97 0.00 0.00
Dividend Declared (₹)
The company has declared dividend 2 times between 19 Mar 2020 and 13 Aug 2020, totaling Rs. 7.00 so far. The most recent dividend was declared on 13 Aug 2020 for Rs. 5.5.

Financial Data Graph

The peers of Eris Lifesciences are AUROPHARMA, INDOCO and UNICHEMLAB.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.